Application no. and date | 19715517.9 (espacenet) (Federated) (European Patent Register), 20190410 | Patent/reg. no. and date | DK/EP 3774838, 20220810 | Publication date | 20210217 | Priority no. and date | EP 18166551, 20180410 | EP pub. no. and date |
EP 3774838 20210217 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstrasse 50
65929 Frankfurt, DE | Applicant ref. no. | 1641561 | Inventor | FIEDLER, Wolfgang, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, HENKEL, Bernd, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, METZENTHIN, Tobias, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, GERKEN, Manfred, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | C07K 1/06 (2006.01) , C07K 14/00 (2006.01) , C07K 14/605 (2006.01) | Title | LIXISENATIDSYNTESE MED CAPPING | Int. application no. | EP2019059090 | Int. publication no. | WO2019197469 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|